Skip to main content
Summer Gibson
( out of 70 reviews )

Summer Gibson, MD

Languages spoken: English

Clinical Locations

  • Dr. Summer Gibson is an associate professor of neurology and chief of the Neuromuscular Medicine Division at the University of Utah. She received her medical degree from the University of Texas Health Science Center San Antonio before completing her neurology residency training and a fellowship in clinical neurophysiology and neuromuscular diseases at the University of Utah.

    Her clinical interests are in neuromuscular disorders and electrodiagnosis (EMG). Within neuromuscular disorders her focus is on amyotrophic lateral sclerosis (ALS), muscular dystrophies, peripheral neuropathies, and myasthenia gravis. She co-directs the motor neuron disease/ALS clinic at the University of Utah.

    She has published extensively in the area of ALS, peripheral neuropathies, and myasthenia gravis. She also participates in clinical trials for diseases in these areas.

    Board Certification

    American Board of Psychiatry & Neurology (Neurology)

    Patient Rating

    4.9 /5
    ( out of 70 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    July 30, 2023
    CLINICAL NEUROSCIENCES CENTER

    Dr. Gibson is well informed, up to date on my disease; caring, warm, very easy to talk with.

    July 09, 2023
    CLINICAL NEUROSCIENCES CENTER

    She was so willing to explain everything Im going through at this time. So grateful for a care ing Dr

    July 08, 2023
    CLINICAL NEUROSCIENCES CENTER

    She was incredible! Very knowledgable and helped to explain the disease. She was understanding and caring to my husband, my daughter and myself. She answered all our questions and is helping us in every way possible to help my husband who is the ALS patient. We felt like we have known her for a long time even though it was the first time we met her. She is the kind of doctor you need and want when something like this disease is diagnosed. It is very evident that she cares about people and that being a doctor is all about giving the best care possible in a positive and caring way.

    July 02, 2023
    CLINICAL NEUROSCIENCES CENTER

    She is an incredible communicator, listens to her patients, and creatively problem solves.

    May 22, 2023
    CLINICAL NEUROSCIENCES CENTER

    She understand me and my condition as well as any physician. And weve know many. Shes excellent in every way.

    May 21, 2023
    CLINICAL NEUROSCIENCES CENTER

    Both times I've met with her she's been patient, fully engaged, happy to answer any questions, and straight, no-BS answers.

    May 20, 2023
    CLINICAL NEUROSCIENCES CENTER

    Dr Gibson is very nice and answers all the questions I have.

    May 20, 2023
    CLINICAL NEUROSCIENCES CENTER

    Great listener, empathetic and genuinely caring.

    May 14, 2023
    CLINICAL NEUROSCIENCES CENTER

    Listened, intrested, compassionate, didn't rush.

  • Dr. Summer Gibson is an associate professor of neurology and chief of the Neuromuscular Medicine Division at the University of Utah. She received her medical degree from the University of Texas Health Science Center San Antonio before completing her neurology residency training and a fellowship in clinical neurophysiology and neuromuscular diseases at the University of Utah.

    Her clinical interests are in neuromuscular disorders and electrodiagnosis (EMG). Within neuromuscular disorders her focus is on amyotrophic lateral sclerosis (ALS), muscular dystrophies, peripheral neuropathies, and myasthenia gravis. She co-directs the motor neuron disease/ALS clinic at the University of Utah.

    She has published extensively in the area of ALS, peripheral neuropathies, and myasthenia gravis. She also participates in clinical trials for diseases in these areas.

    Board Certification and Academic Information

    Academic Departments Neurology -Primary
    Board Certification
    American Board of Psychiatry & Neurology (Neurology)

    Education history

    Certification Responsible Conduct of Research Curriculum - University of Utah Certification
    Clinical Neurophysiology- EMG - University of Utah Fellow
    Chief Resident Neurology - University of Utah Co-Chief Resident
    Neurology - University of Utah Resident
    Internship Medicine - University of Utah Intern
    Medicine - University of Texas Health Science Center at San Antonio M.D.
    Undergraduate Biology - Rice University B.A.

    Selected Publications

    Journal Article

    1. Johnson JO, Chia R, Miller DE, Li R, Kumaran R, Abramzon Y, Alahmady N, Renton AE, Topp SD, Gibbs JR, Cookson MR, Sabir MS, Dalgard CL, Troakes C, Jones AR, Shatunov A, Iacoangeli A, Al Khleifat A, Ticozzi N, Silani V, Gellera C, Blair IP, Dobson-Stone C, Kwok JB, Bonkowski ES, Palvadeau R, Tienari PJ, Morrison KE, Shaw PJ, Al-Chalabi A, Brown RH Jr, Calvo A, Mora G, Al-Saif H, Gotkine M, Leigh F, Chang IJ, Perlman SJ, Glass I, Scott AI, Shaw CE, Basak AN, Landers JE, Chi A, Crawford TO, Smith BN, Traynor BJ, FALS Sequencing Consortium American Genome Center International ALS Genomics Consortium and ITALSGEN Consortium, Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp SD, Scotter EL, Kenna KP, Keagle P, Tiloca C, Vance C, Troakes C, Colombrita C, King A, Pensato V, Castellotti B, Baas F, Ten Asbroek ALMA, McKenna-Yasek D, McLaughlin RL, Polak M, Asress S, Esteban-Prez J, Stevic Z, DAlfonso S, Mazzini L, Comi GP, Del Bo R, Ceroni M, Gagliardi S, Querin G, Bertolin C, van Rheenen W, Rademakers R, van Blitterswijk M, Lauria G, Duga S, Corti S, Cereda C, Corrado L, Sorar G, Williams KL, Nicholson GA, Blair IP, Leblond-Manry C, Rouleau GA, Hardiman O, Morrison KE, Veldink JH, van den Berg LH, Al-Chalabi A, Pall H, Shaw PJ, Turner MR, Talbot K, Taroni F, Garca-Redondo A, Wu Z, Glass JD, Gellera C, Ratti A, Brown RH Jr, Silani V, Shaw CE, Landers JE, Dalgard CL, Adeleye A, Soltis AR, Alba C, Viollet C, Bacikova D, Hupalo DN, Sukumar G, Pollard HB, Wilkerson MD, Martinez EM, Abramzon Y, Ahmed S, Arepalli S, Baloh RH, Bowser R, Brady CB, Brice A, Broach J, Campbell RH, Camu W, Chia R, Cooper-Knock J, Ding J, Drepper C, Drory VE, Dunckley TL, Eicher JD, England BK, Faghri F, Feldman E, Floeter MK, Fratta P, Geiger JT, Gerhard G, Gibbs JR, Gibson SB, Glass JD, Hardy J, Harms MB, Heiman-Patterson TD, Hernandez DG, Jansson L, Kirby J, Kowall NW, Laaksovirta H, Landeck N, Landi F, Le Ber I, Lumbroso S, MacGowan DJL, Maragakis NJ, Mora G, Mouzat K, Murphy NA, Myllykangas L, Nalls MA, Orrell RW, Ostrow LW, Pamphlett R, Pickering-Brown S, Pioro EP, Pletnikova O, Pliner HA, Pulst SM, Ravits JM, Renton AE, Rivera A, Robberecht W, Rogaeva E, Rollinson S, Rothstein JD, Scholz SW, Sendtner M, Shaw PJ, Sidle KC, Simmons Z, Singleton AB, Smith N, Stone DJ, Tienari PJ, Troncoso JC, Valori M, Van Damme P, Van Deerlin VM, Van Den Bosch L, Zinman L, Landers JE, Chi A, Traynor BJ, Angelocola SM, Ausiello FP, Barberis M, Bartolomei I, Battistini S, Bersano E, Bisogni G, Borghero G, Brunetti M, Cabona C, Calvo A, Canale F, Canosa A, Cantisani TA, Capasso M, Caponnetto C, Cardinali P, Carrera P, Casale F, Chi A, Colletti T, Conforti FL, Conte A, Conti E, Corbo M, Cuccu S, Dalla Bella E, DErrico E, DeMarco G, Dubbioso R, Ferrarese C, Ferraro PM, Filippi M, Fini N, Floris G, Fuda G, Gallone S, Gianferrari G, Giannini F, Grassano M, Greco L, Iazzolino B, Introna A, La Bella V, Lattante S, Lauria G, Liguori R, Logroscino G, Logullo FO, Lunetta C, Mandich P, Mandrioli J, Manera U, Manganelli F, Marangi G, Marinou K, Marrosu MG, Martinelli I, Messina S, Moglia C, Mora G, Mosca L, Murru MR, Origone P, Passaniti C, Petrelli C, Petrucci A, Pozzi S, Pugliatti M, Quattrini A, Ricci C, Riolo G, Riva N, Russo M, Sabatelli M, Salamone P, Salivetto M, Salvi F, Santarelli M, Sbaiz L, Sideri R, Simone I, Simonini C, Spataro R, Tanel R, Tedeschi G, Ticca A, Torriello A, Tranquilli S, Tremolizzo L, Trojsi F, Vasta R, Vacchiano V, Vita G, Volanti P, Zollino M, Zucchi E (2021). Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. JAMA Neurol, 78(10), 1236-1248. (Read full article)
    2. Samara VC, Jerant P, Gibson S, Bromberg M (2021). Bowel, bladder, and sudomotor symptoms in ALS patients. J Neurol Sci, 427, 117543. (Read full article)
    3. Russell KL, Downie JM, Gibson SB, Tsetsou S, Keefe MD, Duran JA, Figueroa KP, Bromberg MB, Murtaugh LC, Bonkowsky JL, Pulst SM, Jorde LB (2021). Pathogenic effect of TP73 Gene Variants in People With Amyotrophic Lateral Sclerosis. Neurology. (Read full article)
    4. Alderman A, Hayes H, Gibson S, Bromberg MB (2021). I Want to Row Across the Atlantic. But You Have Amyotrophic Lateral Sclerosis! J Clin Neuromuscul Dis, 22(4), 220-223. (Read full article)
    5. Hayes HA, Hu N, Wang X, Gibson S, Mathy P, Berggren K, Bromberg M (2020). Comparison of driving capacity among patients with amyotrophic lateral sclerosis and healthy controls using the lane change task. J Neurol Sci, 413, 116741. (Read full article)
    6. Howard JF Jr, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Zilucoplan MG Study Group, Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF Jr, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M (2020). Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. JAMA Neurol, 77(5), 582-592. (Read full article)
    7. Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A, ITALSGEN Consortium, Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, DAlfonso S, Corrado L, Capasso M, Ferrucci L, Genomic Translation for ALS Care GTAC Consortium, Moreno CAM, Kamalakaran S, Goldstein DB, ALS Sequencing Consortium, Gitler AD, Harris T, Myers RM, NYGC ALS Consortium, Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC, Answer ALS Foundation, Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E, Clinical Research in ALS and Related Disorders for Therapeutic Development CReATe Consortium, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J, SLAGEN Consortium, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorar G, Cereda C, French ALS Consortium, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC, Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de Belleroche J, Baas F, Ten Asbroek ALMA, Muoz-Blanco JL, Hernandez DG, Ding J, Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S, Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T, Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M, McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R, Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Prez J, Garca-Redondo A, Al-Chalabi A, Project MinE ALS Sequencing Consortium, Rogaeva E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Cooper-Knock J, Brice A, Goutman SA, Feldman EL, Gibson SB, Taroni F, Ratti A, Gellera C, Van Damme P, Robberecht W, Fratta P, Sabatelli M, Lunetta C, Ludolph AC, Andersen PM, Weishaupt JH, Camu W, Trojanowski JQ, Van Deerlin VM, Brown RH Jr, van den Berg LH, Veldink JH, Harms MB, Glass JD, Stone DJ, Tienari P, Silani V, Chi A, Shaw CE, Traynor BJ, Landers JE (2017). Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron, 97(6), 1268-1283.e6. (Read full article)
    8. Aude Nicolas, Kevin P Kenna, Alan E Renton, Nicola Ticozzi, Faraz Faghri, Ruth Chia, Janice A Dominov, Brendan J Kenna, Mike A Nalls, Pamela Keagle, Alberto M Rivera, Wouter van Rheenen, Natalie A Murphy, Joke JFA van Vugt, Joshua T Geiger, Rick A Van der Spek, Hannah A Pliner, Shankaracharya, Bradley N Smith, Giuseppe Marangi, Simon D Topp, Yevgeniya Abramzon, Athina Soragia Gkazi, John D Eicher, Aoife Kenna show ITALSGEN Consortium, Gabriele Mora, Andrea Calvo, Letizia Mazzini, Nilo Riva, Jessica Mandrioli, Claudia Caponnetto, Stefania Battistini, Paolo Volanti, Vincenzo La Bella, Francesca L Conforti, Giuseppe Borghero, Sonia Messina, Isabella L Simone, Francesca Trojsi, Fabrizio Salvi, Francesco O Logullo, Sandra DAlfonso, Lucia Corrado, Margherita Capasso, Luigi Ferrucci, show Genomic Translation for ALS Care GTAC Consortium, Cristiane de Araujo Martins Moreno, Sitharthan Kamalakaran, David B Goldstein, show ALS Sequencing Consortium, Aaron D Gitler, Tim Harris, Richard M Myers, show NYGC ALS Consortium, Hemali Phatnani, Rajeeva Lochan Musunuri, Uday Shankar Evani, Avinash Abhyankar, Michael C Zody, show Answer ALS Foundation, Julia Kaye, Steven Finkbeiner, Stacia K Wyman, Alex LeNail, Leandro Lima, Ernest Fraenkel, Clive N Svendsen, Leslie M Thompson, Jennifer E Van Eyk, James D Berry, Timothy M Miller, Stephen J Kolb, Merit Cudkowicz, Emily Baxi, show Clinical Research in ALS and Related Disorders for Therapeutic Development CReATe Consortium, Michael Benatar, J Paul Taylor, Evadnie Rampersaud, Gang Wu, Joanne Wuu, show SLAGEN Consortium, Giuseppe Lauria, Federico Verde, Isabella Fogh, Cinzia Tiloca, Giacomo P Comi, Gianni Sorar, Cristina Cereda, show French ALS Consortium, Philippe Corcia, Hannu Laaksovirta, Liisa Myllykangas, Lilja Jansson, Miko Valori, John Ealing, Hisham Hamdalla, Sara Rollinson, Stuart Pickering-Brown, Richard W Orrell, Katie C Sidle, Andrea Malaspina, John Hardy, Andrew B Singleton, Janel O Johnson, Sampath Arepalli, Peter C Sapp, Diane McKenna-Yasek, Meraida Polak, Seneshaw Asress, Safa Al-Sarraj, Andrew King, Claire Troakes, Caroline Vance, Jacqueline de Belleroche, Frank Baas, Anneloor LMA ten Asbroek, Jos Luis Muoz-Blanco, Dena G Hernandez, Jinhui Ding, J Raphael Gibbs, Sonja W Scholz, Mary Kay Floeter, Roy H Campbell, Francesco Landi, Robert Bowser, Stefan M Pulst, John M Ravits, Daniel JL MacGowan, Janine Kirby, Erik P Pioro, Roger Pamphlett, James Broach, Glenn Gerhard, Travis L Dunckley, Christopher B Brady, Neil W Kowall, Juan C Troncoso, Isabelle Le Ber, Kevin Mouzat, Serge Lumbroso, Terry D Heiman-Patterson, Freya Kamel, Ludo Van Den Bosch, Robert H Baloh, Tim M Strom, Thomas Meitinger, Aleksey Shatunov, Kristel R Van Eijk, Mamede de Carvalho, Maarten Kooyman, Bas Middelkoop, Matthieu Moisse, Russell L McLaughlin, Michael A Van Es, Markus Weber, Kevin B Boylan, Marka Van Blitterswijk, Rosa Rademakers, Karen E Morrison, A Nazli Basak, Jess S Mora, Vivian E Drory, Pamela J Shaw, Martin R Turner, Kevin Talbot, Orla Hardiman, Kelly L Williams, Jennifer A Fifita, Garth A Nicholson, Ian P Blair, Guy A Rouleau, Jess Esteban-Prez, Alberto Garca-Redondo, Ammar Al-Chalabi, show Project MinE ALS Sequencing Consortium, Ekaterina Rogaeva, Lorne Zinman, Lyle W Ostrow, Nicholas J Maragakis, Jeffrey D Rothstein, Zachary Simmons, Johnathan Cooper-Knock, Alexis Brice, Stephen A Goutman, Eva L Feldman, Summer B Gibson, Franco Taroni, Antonia Ratti, Cinzia Gellera, Philip Van Damme, Wim Robberecht, Pietro Fratta, Mario Sabatelli, Christian Lunetta, Albert C Ludolph, Peter M Andersen, Jochen H Weishaupt, William Camu, John Q Trojanowski, Vivianna M Van Deerlin, Robert H Brown Jr, Leonard H van den Berg, Jan H Veldink, Matthew B Harms, Jonathan D Glass, David J Stone, Pentti Tienari, Vincenzo Silani, Adriano Chi, Christopher E Shaw, Bryan J Traynor (2018). Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron, 97(6), 1268–1283.
    9. Ansari S, Bromberg MB, Gibson SB (2017). Physician perceptions about living organ donation in patients with Amyotrophic Lateral Sclerosis. Clin Neurol Neurosurg, 160, 125-129. (Read full article)
    10. Gibson SB, Downie JM, Tsetsou S, Feusier JE, Figueroa KP, Bromberg MB, Jorde LB, Pulst SM (2017). The evolving genetic risk for sporadic ALS. Neurology, 89(3), 226-233. (Read full article)
    11. Ansari, S, Bromberg, MB, Gibson, SB (2017). Living organ donation in patients with Amyotrophic Lateral Sclerosis. Clin Neurol Neurosurg, 160, 125-129.
    12. Gibson SB, Downie JM, Tsetsou S, Feusier JE, Figueroa KP, Bromberg MB, Jorde LB, Pulst SM (2017). The evolving genetic risk for sporadic ALS. Neurology, 89(3), 226-233.
    13. Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, Ratti E, Atassi N, Boylan KB, Glass JD, Maragakis NJ, Caress JB, McCluskey LF, Appel SH, Wymer JP, Gibson S, Zinman L, Mozaffar T, Callaghan B, McVey AL, Jockel-Balsarotti J, Allred P, Fisher ER, Lopate G, Pestronk A, Cudkowicz ME, Miller TM (2016). Defining SOD1 ALS natural history to guide therapeutic clinical trial design. J Neurol Neurosurg Psychiatry, 88(2), 99-105. (Read full article)
    14. Gibson SB, Abbott D, Farnham JM, Thai KK, McLean H, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L (2016). Population-based risks for cancer in patients with ALS. Neurology, 87(3), 289-94. (Read full article)
    15. Bali T, Self W, Siddique T, Wang LH, Ratti E, Boylan KB, Glass J, Maragakis NJ, Caress JB, Scherer SS, Appel SH, Wymer JP, Gibson SB, Zinman L, Mozaffar T, Jennifer Jockel-Balsarotti J, Allred M, Liu E, Fisher E, Lopate G, Pestronk A, Cudkowicz ME, Miller TM (2016). Survival and disease progression in SOD1 Familial ALS in North America. J Neurol Neurosurg Psychiatry.
    16. Gibson SB, Abbott D, Farnham JM, Thai KK, McLean H, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L (7/19/2016). Population-based risks for cancer in patients with ALS. Neurology, 87(3), 289-294.
    17. Sampson JB, Kerr LM, Gibson SB, Flanigan KM (2009). Aminoglycosides and other nonsense suppression therapies for the treatment of dystrophinopathy. Cochrane Database Syst Rev, (3).
    18. Haringer V, Gibson SB (2015). Amyotrophic lateral sclerosis: clinical perspectives. 5(2015), 19—31.
    19. Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF, Wang Q, Krueger BJ, Ren Z, Keebler J, Han Y, Levy SE, Boone BE, Wimbish JR, Waite LL, Jones AL, Carulli JP, Day-Williams AG, Staropoli JF, Xin WW, Chesi A, Raphael AR, McKenna-Yasek D, Cady J, Vianney de Jong JM, Kenna KP, Smith BN, Topp S, Miller J, Gkazi A, FALS Sequencing Consortium, Al-Chalabi A, van den Berg LH, Veldink J, Silani V, Ticozzi N, Shaw CE, Baloh RH, Appel S, Simpson E, Lagier-Tourenne C, Pulst SM, Gibson S, Trojanowski JQ, Elman L, McCluskey L, Grossman M, Shneider NA, Chung WK, Ravits JM, Glass JD, Sims KB, Van Deerlin VM, Maniatis T, Hayes SD, Ordureau A, Swarup S, Landers J, Baas F, Allen AS, Bedlack RS, Harper JW, Gitler AD, Rouleau GA, Brown R, Harms MB, Cooper GM, Harris T, Myers RM, Goldstein DB (2015). Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science, 347(6229), 1436-41.
    20. Gibson SB, Kasarskis EJ, Hu N, Pulst SM, Mendiondo MS, Matthews DE, Mitsumoto H, Tandan R, Simmons Z, Kryscio RJ, Bromberg MB (2015). Relationship of creatine kinase to body composition, disease state, and longevity in ALS. Amyotroph Lateral Scler Frontotemporal Degener, 16(7-8), 473-7. (Read full article)
    21. Gibson SB, Kasarskis EJ, Hu N, Pulst SM, Mendiondo SM, Matthews DE, Mitsumoto H, Tandan R, Simmons Z, Kryscio RJ, Bromberg MB (2015). Relationship of Creatine Kinase to body composition, disease state, and longevity in ALS. Amyotroph Lateral Scler Frontotemporal Degener, 27, 1-5.
    22. Gibson SB, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L (2014). Familial clustering of ALS in a population-based resource. Neurology, 82(1), 17-22. (Read full article)
    23. Gibson SB, Majersik J, Smith AG, Bromberg MB (2013). Three Cases of Acute Myositis in Adults Following Influenza-like Illness during the H1N1 Pandaemic. J Neurosci Rural Pract, 4, 51.
    24. Gibson SB, Bromberg MB (2012). Amyotrophic lateral sclerosis: drug therapy from the bench to the bedside. (PMID: 23117941). Semin Neurol, 32(3), 173-8.
    25. Gibson SB, Bromberg MB (2012). Amyotrophic lateral sclerosis: drug therapy from the bench to the bedside. Semin Neurol, 32(3), 173-8. (Read full article)

    Review

    1. Breevoort S, Gibson S, Figueroa K, Bromberg M, Pulst S (2022). Expanding Clinical Spectrum of C9ORF72-Related Disorders and Promising Therapeutic Strategies: A Review. [Review]. Neurol Genet, 8(3), e670. (Read full article)

    Case Report

    1. Gibson SB, Majersik JJ, Smith AG, Bromberg MB (2013). Three cases of acute myositis in adults following influenza-like illness during the H1N1 pandemic. J Neurosci Rural Pract, 4(1), 51-4. (Read full article)

    Abstract

    1. Gibson SB, Figueroa KP, Huynh LP, Bromberg MB, Pulst SM (April 29, 2014). Regional Variation of Causative ALS Genes [Abstract]. 66th AAN Annual Meeting.
    2. Gibson SB, Figueroa KP, Huynh LP, Bromberg MB, Pulst SM (2012). Evidence for a Genetic Contribution to ALS Mortality in a Population-based Resource. [Abstract]. 64th AAN Annual Meeting.
  • News & Podcasts